- Our Services
- Meet Our Providers
- Frequently Asked Questions
- Research at the Women's Medicine Collaborative
- Women's Medicine Collaborative Video Library
- Patient Stories
Research at the Women's Medicine Collaborative
Medical Breakthroughs Begin with You
Women have been historically underrepresented in clinical research. Our team strives to research various disorders in women to find answers and provide evidence-based quality care.
Our physicians are board certified and serve on the faculty of The Warren Alpert Medical School of Brown University. Our team is actively involved in clinical research to be sure we are on the cutting edge of research findings to lead the way in advancing women’s medicine and improving the care of women with high-risk pregnancies.
Providers at the Women’s Medicine Collaborative have been awarded industry sponsored and National Institutes of Health (NIH) funded grants to study a variety of health conditions.
Knowledge starts with you! You may be contacted to participate in a research study and to check your eligibility for ongoing studies.
Participation in research is always voluntary; however, it is greatly appreciated.
If you are interested in being considered for participation in one of our studies, please contact us at 401-793-7398 or email WMCResearch@lifespan.org.
Studies Currently Recruiting at the Women's Medicine Collaborative
This study is for individuals with a diagnosis of inflammatory bowel disease (IBD) who have experienced multiple Clostridium difficile infections (C. diff or CDI). This study will assess the efficacy of fecal microbiota transplant (FMT) in combination with an infusion of Bezlotoxumab (an antibody) compared to FMT alone. This research study is funded by Merck and Company.
You may be eligible if you are 18 years of age or older, and have experienced two or more C. diff infections. Learn more.
The Miriam Hospital is conducting a study on the use of e-cigs/vapes, regular cigarettes, alcohol and/or marijuana and stress in daily life among young adults. This research study is funded by the National Institutes of Health.
You may be eligible if you are 18 to 25 years of age and use e-cigs/vapes, regular cigarettes, alcohol and/or marijuana. Learn more.
The Qualitative (study of) Positive Airway Pressure (Q-PAP) study will examine barriers and facilitators to positive airway pressure (PAP) adherence in reproductive age women, pregnant and non-pregnant. Our aim is to examine whether there are barriers and facilitators to PAP therapy that are specific to the pregnant population compared to young, reproductive age non-pregnant women, and to assess whether these experiences vary by race. Long-term goal is to adapt and optimize adherence strategies. This study is funded by the National Institutes of Health (NIH).
You may be eligible if you are a reproductive age woman (18 to 45 years old), non-pregnant or pregnant, and have been diagnosed with obstructive sleep apnea and initiated (or were advised to initiate) PAP therapy. Learn more.
Shared Medical Appointments for Fibromyalgia
Fibromyalgia can be a challenging condition for patients. Living with chronic pain is often difficult and costly to manage. Shared medical appointments (SMAs), or group visits, are a way for patients to have their needs addressed more effectively and provides a platform to share experiences and mutual support with others coping with the same chronic condition.
You may be eligible if you are 18 years of age or older, have been diagnosed with fibromyalgia, if your are not pregnant, and have no severe psychiatric disorders. Learn more.
The SKYLARK STUDY is a research study evaluating an investigational oral medication in women with severe postpartum depression. The purpose of this study is to test the safety and efficacy of an investigational study drug called SAGE-217, a synthetic steroid.
You may be eligible if you are a woman between 18-45 years old, gave birth in the last 12 months, if you frequently feel extremely sad, anxious, or overwhelmed, and feel these symptoms are associated with severe postpartum depression. Learn more.
This study is for individuals who have experienced multiple Clostridium difficile infections (C. diff or CDI). This study will compare the safety, tolerability, and efficacy of CP101, an experimental treatment in capsule form, which is derived from the stools of normal healthy donors who are highly screened, tested, and monitored in structured donation program, to placebo in adults with recurrent Clostridium difficile infection.
You might be eligible to participate if you are 18 years of age or older and have experienced multiple C. diff infections. Learn more.
Sleep and Light Therapy for Perinatal Depression
Researchers at Lifespan are conducting a study looking at whether adding light therapy and a prescribed sleep schedule to usual treatment for depression can speed recovery and prevent postpartum depression.
You might be eligible to participate if you are a healthy pregnant woman age 18 to 40 years old with a current diagnosis of depression. Learn more.
Sleeping For Two
Sleeping for Two is the first part of a research study being conducted at Lifespan that screens and identifies pregnant women who may be experiencing sleep problems. Based on your results, you may be eligible for other research studies. We are working to better understand how sleep problems might affect the health of your pregnancy, and how to prevent pregnancy problems for other women. Learn more.
Past Studies at the Women's Medicine Collaborative
For information about past studies, please contact us at 401-793-7398 or email WMCResearch@lifespan.org.
- Asthma and Mindfulness Study: Asthma Symptom Management Through Mindfulness Training
- PAPSAP Study
- Are You Pregnant? Do You Have Gestational Diabetes?
- Mindfulness and Blood Pressure Study
- Mindfulness and Preterm Birth Study
- Maternal Brain Study: Mindfulness training to reduce risk for HTN